Multiple Organ Failure

PHILADELPHIA —Higher doses of zegocractin significantly reduced severe organ failure and necrotizing pancreatitis in patients with acute pancreatitis and systemic inflammatory response syndrome, according to late-breaking data.

In this Healio video exclusive, Dean Hum, PhD, chief scientific officer at Genfit, outlines five ongoing programs in the company’s acute-on-chronic liver failure development pipeline, which recently were presented at The Liver Meeting.